The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Targeted intra-arterial gemcitabine vs. continuation of IV gemcitabine plus nab-paclitaxel following induction with sequential IV gemcitabine plus nab-paclitaxel and radiotherapy for unresectable locally advanced pancreatic cancer (TIGeR-PaC): A randomized phase 3 multicenter study.
 
Michael J. Pishvaian
Stock and Other Ownership Interests - Perthera; Targeting Resistance in Cancer Cooperative; Tumor Board Tuesday
Consulting or Advisory Role - Astellas Pharma; AstraZeneca/MedImmune; IDEAYA Biosciences; Merck; Novartis; Pfizer; Pionyr; Pionyr; TriSalus Life Sciences
Research Funding - Amgen (Inst); Arcus Biosciences (Inst); BioMed Valley Discoveries (Inst); Hutchison MediPharma (Inst); IDEAYA Biosciences (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); RenovoRx (Inst); Repare Therapeutics (Inst); Seagen (Inst); Takeda (Inst); Tesaro (Inst); Tizona Therapeutics, Inc. (Inst)
Patents, Royalties, Other Intellectual Property - Perthera patient matching algorithm; Use patent for veliparib and FOLFOX
Travel, Accommodations, Expenses - Astellas Pharma
 
Amer H. Zureikat
No Relationships to Disclose
 
Charles D. Lopez
Research Funding - Roche/Genentech (Inst); Taiho Pharmaceutical
 
Kenneth Meredith
No Relationships to Disclose
 
Emmanuel E. Zervos
Consulting or Advisory Role - Medtronic
 
Hassan Hatoum
No Relationships to Disclose
 
Ki Y. Chung
Research Funding - epizyme (Inst); MedImmune (Inst)
 
Daniel James Berg
Research Funding - Amgen (Inst); Array BioPharma (Inst); Merck (Inst); Merck (Inst); Millennium (Inst); Newlink Genetics (Inst)
 
Antonio Ucar
No Relationships to Disclose
 
Ripal T Gandhi
Consulting or Advisory Role - Argon Medical Devices; Becton Dickinson; Boston Scientific; Cordis; Inari; Medtronic; Sirtex Medical; TriSalus Life Sciences
Speakers' Bureau - Genentech; Medtronic; Penumbra; Sirtex Medical
Travel, Accommodations, Expenses - Inari; Sirtex Medical
 
Reza Nazemzadeh
Stock and Other Ownership Interests - Akero Therapeutics; Alector; Amgen; ESSA; Exelixis; Johnson & Johnson; Kura Oncology; Macrogenics
 
Nainesh Parikh
Stock and Other Ownership Interests - Dyve Biosciences; Innovative Health Diagnostics; Truentity
Honoraria - Canon Medical System
Consulting or Advisory Role - Boston Scientific; Canon Medical System
Speakers' Bureau - Canon Medical System
 
Paula M. Novelli
No Relationships to Disclose
 
Brian Kouri
Consulting or Advisory Role - Embolx; GE Healthcare; Medtronic; Sirtex Medical
Speakers' Bureau - Embolx
Research Funding - Sirtex Medical
 
Christopher Laing
Consulting or Advisory Role - Boston Scientific; RenovoRx
Research Funding - Boston Scientific; Johnson & Johnson; RenovoRx
 
Brian A. Boone
No Relationships to Disclose
 
Thor Johnson
Consulting or Advisory Role - Boston Scientific; Medtronic
Speakers' Bureau - Medtronic
Patents, Royalties, Other Intellectual Property - I have developed a portal infusion catheter that is indwelling for the infusion of medications directly into the portal vein - this is patented and currently in animal trials with two collaborators
 
Susan Elaine Bates
Honoraria - Merck (I)
Consulting or Advisory Role - Akita Biomedical (I); ElmediX; Ipsen; OnKure; Pegascy; Progenics (I); Secura Bio (I); SERVIER
Research Funding - Amgen (Inst); Ipsen (Inst); Merck (Inst); Pfizer; Pfizer (Inst); RenovoRx (Inst)
Patents, Royalties, Other Intellectual Property - Patent: Deacetylase Inhibitor Therapy (Inst); Patent: Depsipeptide for Therapy of Kidney Cancer (Inst)
 
Ramtin Agah
Employment - RenovoRx
Leadership - RenovoRx
Stock and Other Ownership Interests - RenovoRx
Patents, Royalties, Other Intellectual Property - RenovoRx
Travel, Accommodations, Expenses - RenovoRx
 
Karyn A. Goodman
Consulting or Advisory Role - Novartis; Philips Healthcare; RenovoRx; Roche/Genentech
Other Relationship - National Cancer Institute